Katharine E. Spink

Overview

Katharine E. Spink received an average of $647K in total compensation, including $247K in salary, at Asterias Biotherapeutics from 2013 to 2016.

Source: SEC filings on May 1, 2017, May 19, 2016, and June 10, 2015.

Related executives

We found six more executives who work or worked at Asterias Biotherapeutics.

Stephen Cartt

Asterias Biotherapeutics

Chief Executive Officer

Pedro Lichtinger

Asterias Biotherapeutics

Chief Executive Officer

Jane Lebkowski

Asterias Biotherapeutics

Chief Scientific Officer

Georgia Erbez

Asterias Biotherapeutics

Chief Financial Officer

Thomas Okarma

Asterias Biotherapeutics

Chief Executive Officer

Michael West

Asterias Biotherapeutics

Vice President of Technology Integration

You may also like